tiprankstipranks
Supernus Pharmaceuticals (SUPN)
NASDAQ:SUPN
US Market
SUPN
Supernus Pharmaceuticals
RESEARCH TOOLSreports
Want to see SUPN full AI Analyst Report?

Supernus Pharmaceuticals (SUPN) Ratios

534 Followers

Supernus Pharmaceuticals Ratios

SUPN's free cash flow for Q4 2025 was $0.89. For the 2025 fiscal year, SUPN's free cash flow was decreased by $ and operating cash flow was
gt;-0.01. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 1.90 1.90 2.35 1.70 1.07
Quick Ratio
 1.66 1.66 2.16 1.43 0.93
Cash Ratio
 0.38 0.38 0.24 0.26 0.14
Solvency Ratio
 0.30 0.13 0.46 0.24 0.18
Operating Cash Flow Ratio
 0.14 0.14 0.59 0.38 0.17
Short-Term Operating Cash Flow Coverage
 0.00 0.00 0.00 0.00 0.29
Net Current Asset Value
$ 253.25M$ 253.25M$ 353.73M$ 136.96M$ -82.15M
Leverage Ratios
Debt-to-Assets Ratio
 0.03 0.03 0.03 0.03 0.26
Debt-to-Equity Ratio
 0.04 0.04 0.03 0.05 0.50
Debt-to-Capital Ratio
 0.04 0.04 0.03 0.04 0.33
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 1.37 1.37 1.32 1.39 1.92
Debt Service Coverage Ratio
 0.00 0.00 0.00 36.68 0.37
Interest Coverage Ratio
 0.00 0.00 0.00 -2.18 6.52
Debt to Market Cap
 0.00 0.00 0.00 0.00 0.21
Interest Debt Per Share
 0.71 0.73 0.62 0.81 8.42
Net Debt to EBITDA
 -0.83 -2.13 -0.20 -0.37 2.29
Profitability Margins
Gross Profit Margin
85.54%89.63%88.23%86.21%86.93%
EBIT Margin
-7.00%-6.82%14.79%0.85%10.16%
EBITDA Margin
14.60%5.70%26.94%14.82%22.98%
Operating Profit Margin
-6.19%-5.13%12.34%-0.87%6.91%
Pretax Profit Margin
-6.82%-6.82%14.79%0.46%9.10%
Net Profit Margin
-5.36%-5.36%11.16%0.22%9.10%
Continuous Operations Profit Margin
-5.36%-5.36%11.16%0.22%9.10%
Net Income Per EBT
78.63%78.63%75.47%47.53%99.95%
EBT Per EBIT
110.12%133.00%119.84%-52.55%131.69%
Return on Assets (ROA)
-2.65%-2.65%5.40%0.10%3.57%
Return on Equity (ROE)
-3.67%-3.63%7.13%0.14%6.85%
Return on Capital Employed (ROCE)
-4.00%-3.31%7.59%-0.53%4.55%
Return on Invested Capital (ROIC)
-3.11%-2.58%5.69%-0.25%3.24%
Return on Tangible Assets
-5.08%-5.08%10.13%0.23%6.88%
Earnings Yield
-1.36%-1.37%3.71%0.08%3.17%
Efficiency Ratios
Receivables Turnover
 3.83 3.83 4.66 4.21 4.03
Payables Turnover
 38.82 27.85 16.98 42.66 8.27
Inventory Turnover
 1.26 0.91 1.43 1.08 0.95
Fixed Asset Turnover
 68.27 68.27 57.32 44.90 43.98
Asset Turnover
 0.49 0.49 0.48 0.48 0.39
Working Capital Turnover Ratio
 2.53 2.06 2.22 4.88 4.01
Cash Conversion Cycle
 375.28 485.53 311.24 415.30 429.49
Days of Sales Outstanding
 95.34 95.34 78.36 86.61 90.53
Days of Inventory Outstanding
 289.34 403.30 254.37 337.24 383.08
Days of Payables Outstanding
 9.40 13.10 21.49 8.56 44.12
Operating Cycle
 384.68 498.64 332.73 423.85 473.61
Cash Flow Ratios
Operating Cash Flow Per Share
 0.83 0.84 3.12 2.04 2.18
Free Cash Flow Per Share
 0.80 0.81 3.11 2.03 2.17
CapEx Per Share
 0.02 0.02 0.01 0.01 <0.01
Free Cash Flow to Operating Cash Flow
 0.97 0.97 1.00 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
 35.37 35.37 237.17 201.61 283.56
Capital Expenditure Coverage Ratio
 35.37 35.37 237.17 201.61 283.56
Operating Cash Flow Coverage Ratio
 1.16 1.16 5.02 2.68 0.26
Operating Cash Flow to Sales Ratio
 0.07 0.07 0.26 0.18 0.18
Free Cash Flow Yield
1.61%1.64%8.59%7.00%6.08%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -74.02 -72.78 26.97 1.20K 31.53
Price-to-Sales (P/S) Ratio
 3.99 3.90 3.01 2.60 2.87
Price-to-Book (P/B) Ratio
 2.69 2.64 1.92 1.71 2.16
Price-to-Free Cash Flow (P/FCF) Ratio
 62.30 61.00 11.64 14.28 16.44
Price-to-Operating Cash Flow Ratio
 60.29 59.28 11.59 14.21 16.39
Price-to-Earnings Growth (PEG) Ratio
 0.75 0.48 <0.01 -12.25 2.65
Price-to-Fair Value
 2.69 2.64 1.92 1.71 2.16
Enterprise Value Multiple
 26.47 66.29 10.98 17.16 14.78
Enterprise Value
 2.76B 2.72B 1.96B 1.54B 2.27B
EV to EBITDA
 26.30 66.29 10.98 17.16 14.78
EV to Sales
 3.84 3.78 2.96 2.54 3.40
EV to Free Cash Flow
 60.02 59.10 11.43 13.98 19.46
EV to Operating Cash Flow
 58.32 57.43 11.38 13.91 19.40
Tangible Book Value Per Share
 6.41 6.51 7.20 3.75 1.24
Shareholders’ Equity Per Share
 18.51 18.81 18.80 16.90 16.51
Tax and Other Ratios
Effective Tax Rate
 0.21 0.21 0.25 0.52 <0.01
Revenue Per Share
 12.54 12.74 12.01 11.14 12.43
Net Income Per Share
 -0.67 -0.68 1.34 0.02 1.13
Tax Burden
 0.79 0.79 0.75 0.48 1.00
Interest Burden
 0.97 1.00 1.00 0.53 0.90
Research & Development to Revenue
 0.15 0.15 0.16 0.15 0.11
SG&A to Revenue
 0.68 0.68 0.51 0.39 0.16
Stock-Based Compensation to Revenue
 0.08 0.05 0.04 0.04 0.03
Income Quality
 -0.65 -1.23 2.33 84.41 1.92
Currency in USD